Effect of cholesterol and ethanol on dermal delivery from DPPC liposomes
Introduction
For the last 2 decades, topical delivery of drugs from liposomal formulations has evoked a considerable interest. Many reports on enhancing percutaneous delivery focus on the use of liposomes, because they can aid the transport of hydrophilic and lipophilic compounds (Coderch et al., 1996). However, it is generally agreed that classic liposomes are of little or no value as carriers for transdermal drug delivery, because they do not deeply penetrate the skin, but rather remain confined to the upper layer of the stratum corneum. Only specially designed vesicles were shown to be able to allow transdermal delivery, such as transfersomes (Cevc et al., 1998, Cevc et al., 2002).
Ethanol is known as an efficient permeation enhancer. This solvent is commonly believed to act by affecting the intercellular region of the stratum corneum (Magnusson et al., 1997), although other mechanisms have been reported, such as coadjuvant to diminish the melting point of drugs, such as lidocaine, achieving a higher concentration in the oil phase of an emulsion and prolonging the anaesthetic latency time (Kang et al., 2001). Its inclusion in liposomes to form ethosomes has already been investigated by other authors (Kirjavainen et al., 1999, Dayan and Touitou, 2000, Godin and Touitou, 2004).
In this study, Mx was selected as a model lipophilic drug. It has potential applications in the case of androgenetic alopecia (Olsen et al., 2002). However, the appearance of some complaints in the patients with this treatment (pruritus and scaling of the scalp) as a consequence of irritant contact dermatitis, allergic contact dermatitis or an exacerbation of seborrheic dermatitis, has been reported (Friedman et al., 2002).
In this paper, vesicle systems (liposomes and ethosomes) were prepared. Ethosomal formulations included ethanol in relatively high concentrations, incorporating it in the aqueous phase. Mx was dissolved in the hydroethanolic solution and was included in the aqueous compartment of vesicles.
This paper focuses on the preparation and characterization of ethosomal formulations, for Mx transdermal delivery. So, the effect of ethanol and CHOL on the permeation of two lipophilic substances (Mx and carotene) through rat skin was evaluated.
Section snippets
Materials
High-purity α-dipalmitoylphosphatidylcholine (α-DPPC) and CHOL were purchased from Sigma (Barcelona, Spain). The lipid purity was higher than 99%, and it was used without further purification. Mx was purchased from Genox Farma (Barcelona, Spain) and was used as a model drug because of its poor water solubility. β-carotene (βC) was used as a fluorescent probe, obtained from Faisa (Seville, Spain).
Chloroform and ethanol were received from Panreac Chemistry (Barcelona, Spain). All other chemicals
Morphology
For an initial vesicle characterization, liposomes and ethosomes were examined by TEM. In all cases, the presence of spherical-shaped vesicles was predominant. The absence of CHOL into the formulations favours the aggregation process among the structures (Fig. 1A). Batches without CHOL (1 and 5) exhibited some vesicle aggregates in the whole vision field (Fig. 1B). This fact has been corroborated by other authors (Coderch et al., 2000, Brisaert et al., 2001), as a consequence of CHOL effect as
Conclusions
In this paper, liposome and ethosome formulations have been characterized, containing Mx as lipophilic drug. When drug-entrapment percentage was determined, it was observed that the presence of ethanol in the aqueous compartment of the vesicles, favoured the Mx-encapsulation, because it was included in the aqueous phase.
In addition, the use of high relative CHOL amount in the lipid fraction of liposomes increased the drug-entrapment percentage, due to the stabilizing effect of this steroid into
Acknowledgements
We are grateful to the Electron Microscopy Service from University of Seville for providing the CLSM and TEM equipment. We also would like to thank to Mrs. Asunción Fernández for her valuable contribution to this work.
References (20)
- et al.
Liposomes with tretinoin: a physical and chemical evaluation
J. Pharm. Biomed. Anal.
(2001) - et al.
Ultraflexible vesicles, transfersomes, have an extremely low pore penetration resistance and transport therapeutic amounts of insulin across the intact mammalian skin
Biochim. Biophys. Acta
(1998) - et al.
Ultradeformable lipid vesicles can penetrate the skin and other semi-permeable barriers unfragmented: evidence from double label CLSM experiments and direct size measurements
Biochim. Biophys. Acta
(2002) - et al.
Percutaneous penetration of liposomes using the tape stripping technique
Int. J. Pharm.
(1996) - et al.
Influence of cholesterol on liposome fluidity by EPR: relationship with percutaneous absorption
J. Control. Rel.
(2000) - et al.
Carriers for skin delivery of trihexyphenidyl HCl: ethosomes vs. liposomes
Biomaterials
(2000) - et al.
Allergic contact dermatitis to topical minoxidil solution: ethiology and treatment
J. Am. Acad. Dermatol.
(2002) - et al.
Mechanism of bacitracin permeation enhancement through the skin and cellular membranes from an ethosomal carrier
J. Contr. Rel.
(2004) - et al.
Preparation and characterization of two-phase melt systems of lidocaine
Int. J. Pharm.
(2001) - et al.
Liposome-skin interactions and their effect on the skin permeation of drugs
Eur. J. Pharm. Sci.
(1999)
Cited by (292)
Synergistic therapeutic effect of ginsenoside Rg3 modified minoxidil transfersomes (MXD-Rg3@TFs) on androgenic alopecia in C57BL/6 mice
2024, International Journal of PharmaceuticsPhospholipid Free Nano-Vesicles of Brinzolamide Biopolymer Ocular Insert; Design, In vitro and In vivo Evaluation
2024, Journal of Pharmaceutical SciencesGout therapeutics and drug delivery
2023, Journal of Controlled ReleaseTransethosome: An ultra-deformable ethanolic vesicle for enhanced transdermal drug delivery
2023, Chemistry and Physics of LipidsTimolol-loaded ethosomes for ophthalmic delivery: Reduction of high intraocular pressure in vivo
2023, International Journal of Pharmaceutics